1-4 of 4
combined intravenous-inhalation induction
Close
Sort by
Journal Articles

Single Agent Ofatumumab In Patients With Relapsed and/Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Results From a Phase II Open Label Study

Jagoda Jasielec, MD, David Peace, MD, Sarah Edwards, MS, Kathy Tolzien, RN, Sonali M. Smith, MD, Chadi Nabhan, MD, FACP
Journal: Blood
Blood (2013) 122 (21): 5131.
https://doi.org/10.1182/blood.V122.21.5131.5131
Published: 2013
Journal Articles

Lenalidomide (LEN) Combined To Intensive Chemotherapy (IC) In AML and Higher Risk MDS With Del 5q. Results Of a Phase I/II Study Of The Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Thomas Prebet, MD PhD, Aspasia Stamatoullas, Christian Recher, MD PhD, Romain Guieze, MD, Emmanuel Raffoux, Krimo Bouabdallah, MD, Mathilde Hunault, Eric Wattel, Laure Stalnikiewicz, MD, Andrea Toma, Herve Dombret, MD, PhD, Norbert Vey, MD PhD, Claude Gardin, MD, Benedicte Samey, Sylvie Chevret, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 620.
https://doi.org/10.1182/blood.V122.21.620.620
Published: 2013
Journal Articles

Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation

Rupali Roy, M.D., Andrew M Evens, DO, MSc, David P. Patton, B.S., Annette Larsen, B.S., R.N., Alfred Rademaker, Ph.D., Jeffrey Cilley, M.D., Stewart Spies, M.D., Daina Variakojis, M.D., Leo I Gordon, M.D., Jane N. Winter, M.D.
Journal: Blood
Blood (2010) 116 (21): 1749.
https://doi.org/10.1182/blood.V116.21.1749.1749
Published: 2010
Journal Articles

Rituximab/Chemotherapy Induction Treatment Followed by High-Dose Therapy and Autologous Transplantation in Patients with Mantle Cell Lymphoma.

C. Thieblemont, D. Antal, L. Lacotte-Thierry, V. Delwail, F. Bouafia, S. Tartas, A.S. Michallet, D. Espinouse, C. Giraud, G. Salles, F. Guilhot, B. Coiffier
Journal: Blood
Blood (2004) 104 (11): 1389.
https://doi.org/10.1182/blood.V104.11.1389.1389
Published: 2004